141 related articles for article (PubMed ID: 21385477)
1. Rate of renal cell carcinoma subtypes in different races.
Sankin A; Cohen J; Wang H; Macchia RJ; Karanikolas N
Int Braz J Urol; 2011; 37(1):29-32;discussion 33-4. PubMed ID: 21385477
[TBL] [Abstract][Full Text] [Related]
2. Multiple Discordant Histology After Nephrectomy: Descriptive Analysis and Outcomes.
Harlow BL; Klaassen Z; Holzman S; Reinstatler L; Franken AA; Kavuri SK; Terris MK; Master VA; Moses KA
Clin Genitourin Cancer; 2016 Apr; 14(2):e171-5. PubMed ID: 26613833
[TBL] [Abstract][Full Text] [Related]
3. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.
Chow WH; Shuch B; Linehan WM; Devesa SS
Cancer; 2013 Jan; 119(2):388-94. PubMed ID: 23147245
[TBL] [Abstract][Full Text] [Related]
4. Racial difference in histologic subtype of renal cell carcinoma.
Olshan AF; Kuo TM; Meyer AM; Nielsen ME; Purdue MP; Rathmell WK
Cancer Med; 2013 Oct; 2(5):744-9. PubMed ID: 24403240
[TBL] [Abstract][Full Text] [Related]
5. Renal cell cancer histological subtype distribution differs by race and sex.
Lipworth L; Morgans AK; Edwards TL; Barocas DA; Chang SS; Herrell SD; Penson DF; Resnick MJ; Smith JA; Clark PE
BJU Int; 2016 Feb; 117(2):260-5. PubMed ID: 25307281
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma.
Alam R; Rezaee ME; Pallauf M; Elias R; Yerrapragada A; Enikeev D; Fang D; Shariat SF; Woldu SL; Ged YMA; Singla N
Urol Oncol; 2023 Nov; 41(11):460.e1-460.e9. PubMed ID: 37709565
[TBL] [Abstract][Full Text] [Related]
7. Patient and tumor characteristics of histological subtypes of renal cell carcinoma and its risk of upstaging to ≥pT3.
Wenzel M; Hoeh B; Cano Garcia C; Bernatz S; Köllermann J; Kluth LA; Chun FKH; Becker A; Mandel P
Urol Oncol; 2023 Dec; 41(12):487.e7-487.e13. PubMed ID: 37758628
[TBL] [Abstract][Full Text] [Related]
8. Clear Cell Papillary Renal Cell Carcinoma: New Clinical and Imaging Characteristics.
Wang K; Zarzour J; Rais-Bahrami S; Gordetsky J
Urology; 2017 May; 103():136-141. PubMed ID: 28130179
[TBL] [Abstract][Full Text] [Related]
9. Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.
Paulucci DJ; Sfakianos JP; Skanderup AJ; Kan K; Tsao CK; Galsky MD; Hakimi AA; Badani KK
Oncotarget; 2017 Jan; 8(3):5196-5205. PubMed ID: 28029648
[TBL] [Abstract][Full Text] [Related]
10. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
11. Histotype predicts the rate of lymph node invasion at nephrectomy in patients with nonmetastatic renal cell carcinoma.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Urol Oncol; 2020 May; 38(5):537-544. PubMed ID: 32122729
[TBL] [Abstract][Full Text] [Related]
12. BAP1 is overexpressed in black compared with white patients with Mx-M1 clear cell renal cell carcinoma: A report from the cancer genome atlas.
Paulucci DJ; Sfakianos JP; Yadav SS; Badani KK
Urol Oncol; 2016 Jun; 34(6):259.e9-259.e14. PubMed ID: 26854086
[TBL] [Abstract][Full Text] [Related]
13. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic disparities in renal cell carcinoma: Increased risk of early-onset and variation in histologic subtypes.
Batai K; Harb-De la Rosa A; Zeng J; Chipollini JJ; Gachupin FC; Lee BR
Cancer Med; 2019 Nov; 8(15):6780-6788. PubMed ID: 31509346
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparities in Histology and Short-Term Renal Functional Outcomes Following Robotic Nephron-Sparing Surgery.
Wang JC; Lai WR; Traore EJ; Liu J; Sholl AB; Mandava SH; Maddox MM; Mitchell GC; Viriyasiripong S; Silberstein JL; Kittles R; Lee BR
Clin Genitourin Cancer; 2017 Apr; 15(2):203-206. PubMed ID: 27554583
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.
Motzer RJ; Bacik J; Mariani T; Russo P; Mazumdar M; Reuter V
J Clin Oncol; 2002 May; 20(9):2376-81. PubMed ID: 11981011
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas.
Rosiello G; Pecoraro A; Luzzago S; Deuker M; Stolzenbach LF; Tian Z; Larcher A; Capitanio U; Montorsi F; Shariat SF; Kapoor A; Saad F; Briganti A; Karakiewicz PI
Cancer Causes Control; 2021 Feb; 32(2):119-126. PubMed ID: 33169306
[TBL] [Abstract][Full Text] [Related]
18. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.
Tripathi RT; Heilbrun LK; Jain V; Vaishampayan UN
Urology; 2006 Aug; 68(2):296-301. PubMed ID: 16904440
[TBL] [Abstract][Full Text] [Related]
19. The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.
Hofmann JN; Schwartz K; Chow WH; Ruterbusch JJ; Shuch BM; Karami S; Rothman N; Wacholder S; Graubard BI; Colt JS; Purdue MP
Cancer Causes Control; 2013 Jan; 24(1):167-74. PubMed ID: 23179659
[TBL] [Abstract][Full Text] [Related]
20. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
